In virio SHAPE analysis of tRNALys3 annealing to HIV-1 genomic RNA in wild type and protease-deficient virus

Retrovirology

Volumn 12, Issue 1, 2015, Pages

  Seif, Elias ^a   Niu, Meijuan ^a   Kleiman, Lawrence ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

annealing; Gag; HIV 1; NCp7; SHAPE; tRNALys3

Indexed keywords

GAG PROTEIN; GENOMIC RNA; LYSINE; PROTEINASE; TRANSFER RNA; 5' UNTRANSLATED REGION; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; LYSINE TRANSFER RNA; NCP7 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; VIRUS RNA;

5' UNTRANSLATED REGION; ACYLATION; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PROMOTER REGION; RNA ANALYSIS; RNA BINDING; RNA STRUCTURE; VIRION; CHEMISTRY; CONFORMATION; DEFICIENCY; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MOLECULAR MODEL; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

5' UNTRANSLATED REGIONS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV PROTEASE; HIV-1; HUMANS; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; RNA, TRANSFER, LYS; RNA, VIRAL;

EID: 84934929716     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/s12977-015-0171-7     Document Type: Article

References (33)

1. Das AT, Klaver B, Berkhout B. Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNALys3. J Virol. 1995;69:3090-7.
2. Li X, Mak J, Arts EJ, Kleiman L, Wainberg MA, Parniak MA. Effects of alternations of primer binding site sequences on HIV-1 replication. J Virol. 1994;68:6198-206.
3. Wakefield JK, Wolf AG, Morrow CD. Human immunodeficiency virus type 1 can Use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNALys3. J Virol. 1995;69:6021-9.
4. Lys3 (template/primer) complex. J Mol Biol. 1995;247:236-50.
5. Isel C, Marquet R, Keith G, Ehresmann C, Ehresmann B. Modified nucleotides of tRNALys3 modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription. J Biol Chem. 1993;268:25269-72.
6. Goldschmidt V, Paillart JC, Rigourd M, Ehresmann B, Aubertin AM, Ehresmann C, et al. Structural variability of the initiation complex of HIV-1 reverse transcription. J Biol Chem. 2004;279:35923-31.
7. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess Jr JW, Swanstrom R, et al. Architecture and secondary structure of an entire HIV-1 RNA genome.Nature. 2009;460:711-6.
8. Beerens N, Groot F, Berkhout B. Inititation of HIV-1 reverse transcription is regulated by a primer activation signal. JBiol Chem. 2001;276:31247-56.regulated by a primer activation signal. JBiol Chem. 2001;276:31247-56.
9. Beerens N, Berkhout B. The tRNA primer activation signal in the human immunodeficiency virus type 1 genome is important for initiation and processive elongation of reverse transcription. J Virol. 629 2002;76:2329-39.
10. Guo F, Cen S, Niu M, Yang Y, Gorelick RJ, Kleiman L. The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA. J Virol. 2007;81:11322-31.
11. Xing L, Liang C, Kleiman L. Coordinate Roles of Gag and RNA Helicase A in Promoting the Annealing of Formula to HIV-1 RNA. J Virol. 2011;85:1847-60.
12. Lys3 to human immunodeficiency virus type 1 genomic RNA. J Virol. 1999;73:4485-8.
13. Saadatmand J, Kleiman L. Aspects of HIV-1 assembly that promote primer tRNA(Lys3) annealing to viral RNA. Virus Res. 2012;169:340-8.
14. Pavon-Eternod M, Wei M, Pan T, Kleiman L. Profiling non-lysyl tRNAs in HIV-1. RNA. 2010;16:267-73.
15. van Weringh A, Ragonnet-Cronin M, Pranckeviciene E, Pavon-Eternod M, Kleiman L, Xia X. HIV-1 modulates the tRNA pool to improve translation efficiency. Mol Biol Evolution. 2011, in press.
16. Lys3 genomic placement and the initiation step of reverse transcription in HIV-1. J Virol. 2000;74:10796-800.
17. Guo F, Saadatmand J, Niu M, Kleiman L. Roles of Gag and NCp7 in facilitating tRNA(Lys)(3) Annealing to viral RNA in human immunodeficiency virus type 1. J Virol. 2009;83:8099-107.
18. Kaplan AH, Manchester M, Swanstrom R. The activity of the protease of Human Immunodeficiency Virus Type 1 is initiated at the membrane of infected cells before the release to occur with maximum efficiency. J Virol. 1994;68:6782-6.
19. Wilkinson KA, Gorelick RJ, Vasa SM, Guex N, Rein A, Mathews DH, et al. High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states. PLoS Biol. 2008;6:e96.
20. Seif E, Niu M, Kleiman L. Annealing to sequences within the primer binding site loop promotes an HIV-1 RNA conformation favoring RNA dimerization and packaging. RNA. 2013, 19(10).
21. Bell NM, Kenyon JC, Balasubramanian S, Lever AM. Comparative structural effects of HIV-1 Gag and nucleocapsid proteins in binding to and unwinding of the viral RNA packaging signal. Biochemistry. 2012;51:3162-9.
22. Wu T, Datta SA, Mitra M, Gorelick RJ, Rein A, Levin JG. Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications. Virology. 2010;405:556-67.
23. Darlix JL, Godet J, Ivanyi-Nagy R, Fosse P, Mauffret O, Mely Y. Flexible nature and specific functions of the HIV-1 nucleocapsid protein. J Mol Biol. 2011;410:565-81.
24. Jones CP, Datta SA, Rein A, Rouzina I, Musier-Forsyth K. Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding. J Virol. 2011;85:1594-603.
25. Graham WD, Barley-Maloney L, Stark CJ, Kaur A, Stolarchuk C, Sproat B, et al. Functional recognition of the modified human tRNALys3(UUU) anticodon domain by HIV's nucleocapsid protein and a peptide mimic. J Mol Biol. 2011;410:698-715.
26. Levin JG, Mitra M, Mascarenhas A, Musier-Forsyth K. Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription. RNA Biol. 2010;7:754-74.
27. Halwani R, Cen S, Javanbakht H, Saadatmand J, Kim S, Shiba K, et al. Cellular distribution of Lysyl-tRNA synthetase and its interaction with Gag during human immunodeficiency virus type 1 assembly. J Virol. 2004;78:7553-64.
28. Jones CP, Saadatmand J, Kleiman L, Musier-Forsyth K. Molecular mimicry of human tRNALys anti-codon domain by HIV-1 RNA genome facilitates tRNA primer annealing. RNA. 2013;19:219-29.
29. Moore MD, Fu W, Nikolaitchik O, Chen J, Ptak RG, Hu WS. Dimer initiation signal of human immunodeficiency virus type 1: its role in partner selection during RNA copackaging and its effects on recombination. J Virol. 2007;81:4002-11.
30. Moore MD, Nikolaitchik OA, Chen J, Hammarskjold ML, Rekosh D, Hu WS. Probing the HIV-1 genomic RNA trafficking pathway and dimerization by genetic recombination and single virion analyses. PLoS Pathog. 2009;5:e1000627.
31. Terwilliger EF, Cohen EA, Lu YC, Sodroski JG, Haseltine WA. Functional role of Human Immunodeficiency Virus Type 1 Vpu. Proc Natl Acad Sci U S A. 1989;86:5163-7.
32. Göttlinger HG, Sodroski JG, Haseltine WA. Role of Capsid Precursor Processing and Myristoylation in Morphogenesis and Infectivity of Human Immunodeficiency Virus Type 1. Proc Natl Acad Sci U S A. 1989;86:5781-5.
33. Pang PS, Elazar M, Pham EA, Glenn JS. Simplified RNA secondary structure mapping by automation of SHAPE data analysis. Nucleic Acids Res. 2011;39, e151.